Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Khorasani, F. Chung, P. Bhavsar (United Kingdom). Expression of lipopolysaccharide and dexamethasone-induced MKP-1 in PBMCs of patients with severe or non-severe asthma. Eur Respir J 2010; 36: Suppl. 54, 4314

Member's Comments

No comment yet.

Related content which might interest you: Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Cytokine receptors expression in induced sputum in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Assessment of cytokine mRNA expression in patients with COPD exacerbations Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Induction of cathelicidin (LL-37) in rhinovirus-induced COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Expression of the glucocorticoid β receptor in the sputum of moderate and severe asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 412s Year: 2003 Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Long-term use of ICS influence TLR2 expression on induced sputum from severe COPD patients Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 Cytokine upregulation in the diaphragm of severe COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009 Respiratory syncytial-virus induced cytokine production from leukocytes is impaired in severe asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017 Year: 2017 Increase in systemic IL-5 is associated with mepolizumab treatment failure in patients with severe asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021 LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Serum Amphiregulin expression in severe asthma patients treated with anti-IL-5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017 Aspirin enhances the CD11b expression of eosinophils in patients with aspirin-intolerance asthma Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003